PFBT
ALNY icon

Parkside Financial Bank & Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.4K Buy
101
+4
+4% +$1.36K ﹤0.01% 1125
2025
Q4 		$38.6K Sell
97
-82
-46% -$36.3K ﹤0.01% 1059
2025
Q3 		$81.6K Hold
179
– – 0.01% 742
2025
Q2 		$58.4K Buy
179
+44
+33% +$12.2K 0.01% 850
2025
Q1 		$36.5K Buy
135
+79
+141% +$20.3K ﹤0.01% 939
2024
Q4 		$13.2K Hold
56
– – ﹤0.01% 1214
2024
Q3 		$15.4K Buy
56
+15
+37% +$3.9K ﹤0.01% 1129
2024
Q2 		$9.96K Buy
41
+5
+14% +$789 ﹤0.01% 1183
2024
Q1 		$5.38K Sell
36
-2
-5% -$334 ﹤0.01% 1326
2023
Q4 		$7.27K Buy
38
+13
+52% +$2.21K ﹤0.01% 1218
2023
Q3 		$4.43K Buy
25
+2
+9% +$382 ﹤0.01% 1411
2023
Q2 		$4.37K Buy
23
+3
+15% +$595 ﹤0.01% 1423
2023
Q1 		$4.01K Sell
20
-2
-9% -$420 ﹤0.01% 1449
2022
Q4 		$5.23K Hold
22
– – ﹤0.01% 1305
2022
Q3 		$5K Buy
22
+2
+10% +$381 ﹤0.01% 1189
2022
Q2 		$2K Sell
20
-11
-35% -$1.56K ﹤0.01% 1522
2022
Q1 		$5K Sell
31
-4
-11% -$609 ﹤0.01% 1269
2021
Q4 		$6K Buy
35
+4
+13% +$743 ﹤0.01% 1209
2021
Q3 		$6K Buy
31
+5
+19% +$938 ﹤0.01% 1141
2021
Q2 		$4K Buy
26
+6
+30% +$879 ﹤0.01% 1289
2021
Q1 		$3K Hold
20
– – ﹤0.01% 1340
2020
Q4 		$3K Buy
+20
New +$2.67K ﹤0.01% 1261
2019
Q4 		– Sell
-13
Closed -$1K – 1577
2019
Q3 		$1K Buy
+13
New +$1.03K ﹤0.01% 1277
2016
Q1 		– Sell
-35
Closed -$3K – 1037
2015
Q4 		$3K Sell
35
-33
-49% -$3.06K ﹤0.01% 827
2015
Q3 		$5K Buy
+68
New +$7.55K ﹤0.01% 771

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's ALNY Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Alnylam Pharmaceuticals (ALNY) stake by 4.1% in Q1 2026, buying an estimated $1.36K and bringing the position to 101 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Parkside Financial Bank & Trust first reported a position in ALNY in Q3 2015 and has held it in 25 quarters since. The position peaked at $81.6K in Q3 2025. 789 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Parkside Financial Bank & Trust held 101 shares of Alnylam Pharmaceuticals worth $33.4K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 4 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.36K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1125 holding.
  • Parkside Financial Bank & Trust first reported a position in Alnylam Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
  • Parkside Financial Bank & Trust's Alnylam Pharmaceuticals position peaked at $81.6K in Q3 2025.
  • 789 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.